Bergeson & Campbell, P.C.
Rich Engler has extensive experience in the field of chemistry. Rich started their career in 1995 as a Lecturer at the University of California, San Diego, where they taught for two years. In 1997, they joined the University of San Diego as a Lecturer for a brief period before transitioning to the US EPA. At the EPA, Rich worked as a Chemist from 1997 to 2015, with a temporary assignment in the Marine Pollution Control Branch in 2010-2011. Rich then became a Program Manager for the Green Chemistry Program from 2002 to 2010, overseeing initiatives and representing the program to various audiences. In 2010, Rich joined UC Berkeley Extension as an Online Course Instructor and Course Developer. Rich held these positions until 2014. In 2015, Rich moved on to work for Bergeson & Campbell, P.C. and The Acta Group as a Senior Chemist and later as the Director of Chemistry. Rich still holds these roles. Overall, Rich Engler has a diverse background in chemistry, teaching, and program management.
Rich Engler attended Westtown School from 1979 to 1983, though no degree or field of study is provided for this period. Rich then pursued a Bachelor of Science (BS) degree in Chemistry at Haverford College from 1983 to 1987. After completing their undergraduate studies, Rich Engler went on to pursue a PhD in Organic Chemistry at UC San Diego, which they completed between 1987 and 1995.
This person is not in any teams
This person is not in any offices
Bergeson & Campbell, P.C.
Bergeson & Campbell, P.C. is an AV-rated (highest ranking) Washington, D.C. law firm focusing on conventional and nanoscale, industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Bergeson & Campbell`s clients are involved in many businesses, including conventional and nanoscale, basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products. We represent and counsel individuals, business entities, trade associations, and industry coalitions. Our professionals conduct advocacy before EPA, FDA, HHS, OSHA, ATSDR, NTP, OMB, the Departments of State, Interior, and U.S. Special Trade Representative, state governmental bodies, federal and state courts, and in other forums, and play active roles in business strategy development, compliance planning, toxic tort defense, acquisitions, and related activities.